Stifel Nicolaus Reaffirms Buy Rating for OptimizeRx (NASDAQ:OPRX) theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
Citigroup Inc. decreased its position in shares of OptimizeRx Co. (NASDAQ:OPRX – Free Report) by 45.0% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 6,189 shares of the company’s stock after selling 5,070 shares during the period. Citigroup Inc.’s […]
Operator: Good morning, everyone and thank you for joining OptimizeRx’s Fourth Quarter Fiscal 2023 Conference Call. With us today is the Chief Executive Officer of OptimizeRx, William Febbo.
OptimizeRx (OPRX) Set to Announce Quarterly Earnings on Thursday themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
OptimizeRx Co. (NASDAQ:OPRX – Get Free Report) has received a consensus recommendation of “Moderate Buy” from the six analysts that are covering the firm, MarketBeat Ratings reports. One analyst has rated the stock with a hold rating and five have assigned a buy rating to the company. The average twelve-month price objective among brokerages that […]